Trial of Myocet in Metastatic Breast Cancer

Sponsor
Sopherion Therapeutics (Industry)
Overall Status
Unknown status
CT.gov ID
NCT00294996
Collaborator
(none)
363
105
3.5

Study Details

Study Description

Brief Summary

The purpose of the study is to examine the safety and effectiveness of the drug combination of Myocet, paclitaxel and trastuzumab compared to paclitaxel and trastuzumab without Myocet, as first line treatment for patients with metastatic HER2+ breast cancer.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
363 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase III Randomized, Controlled Trial of Myocet, Trastuzumab and Paclitaxel Versus Trastuzumab and Paclitaxel for First-Line Therapy of Metastatic Breast Cancer
Study Start Date :
Jan 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Progression-Free Survival []

Secondary Outcome Measures

  1. Overall Survival []

  2. Safety []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Metastatic Her2+ Breast cancer by FISH analysis

  • No prior chemotherapy for metastatic disease

  • Measurable disease

  • normal left ventricular ejection fraction

Exclusion Criteria:
  • prior doxorubicin treatment exceeding 300 mg/m2 or epirubicin exceeding 600 mg/m2

  • relapse within 12 months of completion of adjuvant trastuzumab, taxane or anthracycline therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Scripps Cancer Center Clinical Research San Diego California United States 92121
2 University of Colorado Aurora Colorado United States 80045
3 Northwest Hematology/Oncology Associates Coral Springs Florida United States 33065
4 Osceola Cancer Center Kissimmee Florida United States 34741
5 UM/Sylvester Cancer Center Plantation Florida United States 33324
6 John B. Amos Cancer Center Columbus Georgia United States 31904
7 Clintell, Inc Skokie Illinois United States 60076
8 Hutchinson Clinic P.A. Hutchinson Kansas United States 67502
9 Western Maryland Health System Cumberland Maryland United States 21502
10 Brody School of Medicine @ ECU Greenville North Carolina United States 27834
11 Aultman Hospital Cancer Center Canton Ohio United States 44710
12 Hematology Oncology Consultants, Inc. Columbus Ohio United States 43235
13 Vita Hematology Oncology Bethlehem Pennsylvania United States 18015
14 Hematology & Oncology Associates of NEPA Dunmore Pennsylvania United States 18512
15 PA Oncology Hematology Asso Philadelphia Pennsylvania United States 19106
16 M. Francisco Gonzalez Columbia South Carolina United States 29203
17 Sioux Valley Clinic Sioux Falls South Dakota United States 57104
18 Tennessee Cancer Specialists Knoxville Tennessee United States 37920
19 Centro Oncologico de Excelencia Buenos Aires Argentina
20 Hospital Enrique Tornú Buenos Aires Argentina
21 Hospital Interzonal Gral de Agudos " EVITA" Buenos Aires Argentina
22 Hospital Profesor A. Posadas Buenos Aires Argentina
23 Santorio Municipal Dr. J. Mendez Buenos Aires Argentina
24 Unidad Oncologica del Neuquen Neuquen Argentina
25 CAICI Instituto Santa Fe Argentina
26 Centro Oncologico Rosario Santa Fe Argentina
27 ISIS Clinica Especializada Santa Fe Argentina
28 Ceten Villa Dominico Argentina
29 Dr. Leon Richard Oncology Centre Moncton New Brunswick Canada E1C 8X3
30 QEII Health Sciences Centre Halifax Nova Scotia Canada B3H 1V7
31 London Regional Cancer Centre/London Health Science Centre London Ontario Canada N6A 4L6
32 The Ottawa Hospital Regional Cancer Center Ottawa Ontario Canada K1H 8L6
33 Princess Margaret Hospital Toronto Ontario Canada M5G 2M9
34 CHUM Hospital Notre-Dame Montreal Quebec Canada H2L 4M1
35 McGill University Montreal Quebec Canada H2W 1S6
36 Allan Blair Cancer Centre Regina Saskatchewan Canada S47 7T1
37 Saskatoon Cancer Centre Saskatoon Saskatchewan Canada S7N 4H4
38 Hopital du St. Sacrement Quebec Canada G1S 4L8
39 U.K Charité, Campus Mitte Berlin Germany
40 Universitätsklinikum Magdeburg Magdeburg Germany
41 Gemeinschaftspraxis Gynäkologie & Geburtshilfe Mannheim Germany
42 Frauenklinik von Roten Kreuz München Germany
43 Klinikum Offenbach Offenbach Germany
44 Üniversitäts Klinikum Tübingen Tübingen Germany
45 Dr. Horst Schmidt Kliniken Wiesbaden Germany
46 Gujarat Cancer Research Institute Asarwa Gujarat India
47 Kidwai Memorial Institute of Oncology Bangalore India
48 Manipal Hospital Bangalore India
49 Apollo Specialty Hospitals, Chennai Chennai India
50 Nizam's Institute of Medical Science Hyderabaad India
51 SMSMedicalCollegeHospital, Jaipur India
52 Lakeshore Hospital and Research Centre Ltd Kerala India
53 Himadri cancer welfare trusr Kolkata India
54 Orchid Nursing Home, Kolkata India
55 Ruby Hall Clinic Maharashtra India
56 Tata Memorial Hospital Maharashtra India
57 Kasturba Medical College, Mangalore India
58 Jaslok Hospital and Research Centre Mumbai India
59 Batra Hospital & Medical Research Center New Delhi India
60 Indraprastha Apollo Hospitals New Delhi India
61 Safdarjung Hospital & Vardhaman Mahaveer Medical College New Delhi India
62 Fortis Hospital Noida India
63 Azienda Ospedialera Pugliese-Ciaccio Catanzaro Italy
64 Clinica Oncologica Ospedale Chieti Italy
65 DIMI - Università di Genova Genova Italy
66 ARNAS CIVICO. Presidio Ospedaliero M. Ascoli Palermo Italy
67 Oncologia Medica Pavia Italy
68 Day Hospital Oncologico, Roma Italy
69 Istituto Clinico Humanitas Rozzano Italy
70 SP SK nr1 ACK AMG Gdańsk Poland
71 Centrum Onkologii - Instytut Marii Skłodowskiej-Curie Oddział Gliwice Gliwice Poland
72 Samodzielny Publiczny Szpital Lublin Poland
73 Zakład Opieki Zdrowotnej MSWiA Olsztyn Poland
74 Szpital Wojewódzki im. Św. Łukasza Tarnow Poland
75 Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Warszawa Poland
76 Wojskowy Instytut Medyczny Warszawa Poland
77 SP ZOZ Szpital Wojewódzki Zielona Gora Poland
78 Regionalny Ośrodek Onkologiczny Łódź Poland
79 Regionalny Szpital Specjalistyczny Świdnica Poland
80 nstituto Português de Oncologia Francisco Gentil Lisbon Portugal
81 Non-state Health Care Insitution "N.A. Semashko Central Clinical Hospital #2" of the "Russian Railways" Joint Stock Company Moscow Russian Federation
82 State Institution "N.N. Blokhin Russian Oncology Scientific Center" of the Russian Academy of Medical Sciences Moscow Russian Federation
83 State Science Institution "P.A. Hertzen Moscow Oncology Research Institute" of the Federal Agency of Health Care and Social Development Moscow Russian Federation
84 State Health Care Institution "Regional Clinical Oncology Dispensary" Ryazan Russian Federation
85 Municipal Health Care Institution of the City of Sochi "Oncology Dispensary" Sochi Russian Federation
86 St. Petersburg State Health Care Institution "City Clinical Oncology Dispensary" St Petersberg Russian Federation
87 State Science Institution "Prof. N.N. Petrov Research Institute of Oncology" of the Federal Agency of Health Care and Social Development St Petersberg Russian Federation
88 Research Institute of Pulmonology affiliated with State Educational Institution "St. Petersburg State Medical University n.a. academician I.P. Pavlov" of the Federal Agency of Health Care and Social Development St. Petersberg Russian Federation
89 State Health Care Institution "Leningrad Regional Oncology Dispensary" St. Petersburg Russian Federation
90 State Health Care Institution of the Yaroslavl Region "Yaroslavl Regional Oncology Dispensary" Yaroslavl Russian Federation
91 Hospital de la Santa Creu i Sant Pau Barcelona Spain
92 Hospital Universitario Vall d'Hebron Barcelona Spain
93 Hospital Universitari Arnau de Vilanova de Lleida Lleida Spain
94 Hospital 12 de Octubre Madrid Spain
95 Hospital Son Dureta Palma de Mallorca Spain
96 Hospital Clínico Universitario de Salamanca Salamanca Spain
97 Hospital Virgen Macarena Sevilla Spain
98 Hospital Mutua de Terrassa Terrassa Spain
99 Hospital Clínico Universitario de Valencia Valencia Spain
100 Hospital General Universitario de Valencia Valencia Spain
101 Hospital Clínico Universitario Lozano Blesa Zaragoza Spain
102 Broomfield Hospital Broomfield United Kingdom
103 Christie Hospital NHS Trust Cardiff United Kingdom
104 Guy's Hospital London United Kingdom
105 Royal Free Hospital London United Kingdom

Sponsors and Collaborators

  • Sopherion Therapeutics

Investigators

  • Principal Investigator: Jose Baselga, M.D., Vall d'Hebron Hospital, Barcelona, Spain

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00294996
Other Study ID Numbers:
  • STM01-102
First Posted:
Feb 22, 2006
Last Update Posted:
Mar 31, 2009
Last Verified:
Mar 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2009